Rutgers University is a clinical trial site for the Janssen Pharmaceutical Companies of Johnson & Johnson’s phase 3 clinical research study to evaluate the safety and efficacy of Janssen’s COVID-19 vaccine candidate. Rutgers will enroll as many as 2,000...
The Rutgers Institute for Health, Health Care Policy and Aging Research has received $10 million in funding from the Robert Wood Johnson Foundation and Rutgers University to support the New Jersey Population Health Cohort Study – the largest study to date to explore...
Researchers tested nearly 4,000 employees and clinicians at Robert Wood Johnson University Hospital in New Brunswick, NJ, between April 28 and June 30, following a COVID-19 surge in the Garden State that began in March. Of those tested, 13 employees had COVID-19, and...
Dr. Rey Panettieri, Rutgers Robert Wood Johnson Medical School professor of medicine, joins ‘Power Lunch’ to discuss Pfizer’s coronavirus vaccine and the concerns some people may have with it. To watch the interview.
